Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora’s Box of Multiple Myeloma
Bone marrow (BM) aspirates are the gold standard for patient prognostication and genetic characterization in multiple myeloma (MM). However, they represent an important limitation for periodic disease monitoring because they entail an aggressive procedure. Moreover, recent findings show that a singl...
Main Authors: | Juan-José Garcés, Jesús San-Miguel, Bruno Paiva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/6/1430 |
Similar Items
-
Circulating Tumor Cells, Enumeration and Beyond
by: Jian-Mei Hou, et al.
Published: (2010-06-01) -
A Review of Circulating Tumour Cell Enrichment Technologies
by: Amelia J. Rushton, et al.
Published: (2021-02-01) -
Utility of Circulating Cell-Free RNA Analysis for the Characterization of Global Transcriptome Profiles of Multiple Myeloma Patients
by: Maoshan Chen, et al.
Published: (2019-06-01) -
Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer
by: Lucile Broncy, et al.
Published: (2019-07-01) -
Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients
by: Katharina Gorges, et al.
Published: (2019-10-01)